SB-01 For Injection for intervertebral disc degeneration

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Aug 2022: Trial started, NCT05516992
  2. 26 Aug 2022: Trial registered, NCT05516992

The trials

NCT05516992: Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine

State
Under way
Phase
Phase 3
People
417 taking part
Started
19 Aug 2022
Primary completion
21 Mar 2025
Arms
SB-01 For Injection
Results
None posted
  1. 19 Aug 2022: Trial started
  2. 26 Aug 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.